NG-350A

N/A

Report date: 2025/10/21 14:45:43

Base Information

Drug NameNG-350A
Drug Alias NameNG-350A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adenoviral vector
Mechanisms of ActionGene transferenceAnti-CD40
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsNeoplasm MetastasisRectal NeoplasmsNeoplasms, Glandular and Epithelial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAkamis Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAkamis Bio LtdXuanzhu (Shijiazhuang) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasm MetastasisRectal NeoplasmsNeoplasms, Glandular and Epithelial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A